Compare CVS Health Corp (CVS) vs Tidewater Inc (TDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Tidewater Inc — how do they compare? CVS Health Corp trades at $86.3 (market cap $112.49B), while Tidewater Inc trades at $84.73 (market cap $4.15B). The key difference: CVS Health Corp is far larger — about 27.1× Tidewater Inc's market cap, and CVS Health Corp pays a 3.02% dividend while Tidewater Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Tidewater Inc for 25 Days on average.
| CVS | TDW | |
|---|---|---|
Market Cap | $112.49B | $4.15B |
Volume | 8,467,392 | 662,838 |
Sector | Health | Energy |
52-Week High | $110.60 | $100.61 |
52-Week Low | $70.08 | $47.29 |
Typical Hold Time | 83 Days | 25 Days |
Enterprise Value | $174.83B | $4.19B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Tidewater (TDW) trades at $83.40, up 1.62% with a bullish technical outlook supported by moving averages. The company maintains strong profitability with 18.34% net margins and 19.49% ROE, though recent Q2 2026 earnings missed expectations. Recent developments include the completion of Wilson Sons Ultratug acquisition in August 2026 and significant institutional buying from BlackRock.
TDW presents a mixed outlook with solid fundamentals but recent earnings volatility. The 26% upside to consensus price target of $105.50 offers potential, though execution risks from integration challenges and competitive pressures warrant caution. Institutional accumulation and bullish technicals support near-term strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Tidewater Inc
Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →
